National and Kapodistrian University of Athens
Διερεύνηση της γενετικής ετερογένειας των γονιδίων τεσσάρων αιμοπεταλιακών γλυκοπρωτεϊνικών υποδοχέων και διακυτταρικών συνδέσμων σε γυναίκες με αποβολές και αποτυχίες εμφύτευσης μετά απο εξωσωματική γονιμοποίηση και εμβρυομεταφορά
Abstract
dc:descriptionSpontaneous miscarriages are the most common complications of pregnancy, and implantation failures after successful in vitro fertilization and embryo-transfer (IVF-ET failures) constitute the major determinant of total IVF treatment failure. Credible evidence suggests that these disorders share common pathogenetic mechanisms. Genetic thrombophilic factors have been associated with miscarriages, whereas evidence for their role in IVF implantation outcome has been less clear. Glycoproteins Ia (GpIa) and IIIa (GpIIIa) are platelet receptors which mediate sequentially platelet activation and aggregation, while PECAM-1 and P-Selectin are cell adhesion molecules involved in the interactions among platelets, leukocytes and endothelial cells. The aim of this study is to investigate the associations of the genetic heterogeneity GpIa-C807T (rs1126643), GpIIIa-T1565C-PlA1/PlA2 (rs5918), PECAM-1-C373G (Leu125Val) (rs668) and P-Selectin-A37674C (Thr715Pro) (rs6136) with the risk of miscarriages and IVF-ET failures. Material and Methods: Three hundred forty-two women of Greek origin were included in this study. Specifically, 60 nulligravidous women aged 24-40 years with previous IVF-ET failures after exclusion of other known associated etiological factors, 222 nulliparous women aged 23-40 years who experienced spontaneous miscarriages <20 weeks of gestation after natural conception and were tested negative for established risk factors for miscarriages, and 60 fertile controls without history of pregnancy complications or premature cardiovascular events among first-degree relatives, were genotyped for the 4 genetic polymorphisms by pyrosequencing. Relative risk analysis was performed by maternal age and gestational age (early miscarriages: embryonic period, <10 gestational weeks; late miscarriages: fetal period, ≥10 gestational weeks). Genetic models are presented, based on the total number of genetic loci carrying polymorphic alleles (dominant) and the total number of polymorphic alleles (additive) per subject. Statistical analysis was performed by using logistic regression and ROC (Receiver operating characteristic) analysis.Results: All genotype frequencies in cases and controls were in accordance with the Hardy-Weinberg equilibrium. A statistically significant association between the GpIa-C807T genetic heterogeneity and the risk of IVF-ET failure was observed. In comparison with women with the CC genotype, carriers of the GpIa-807T allele had OR=3.45 (95%CI: 1.63-7.30, p=0.001), with the risk being higher for homozygotes TT (OR=7.43, 95%CI: 1.44-38.21, p=0.013) than heterozygotes CT (OR=3.03, 95%CI: 1.39-6.61, p=0.005) (p<0.001 for trend). Additionally, the genetic heterogeneity GpIIIa-T1565C-PlA1/PlA2 was associated with IVF-ET failures risk (carriers of the GpIIIa-PlA2 allele: OR=2.86, 95%CI: 1.27-6.45, p=0.010). Furthermore, PECAM-1-C373G (Leu125Val) genetic heterogeneity was statistically significantly associated with IVF-ET failures, with OR=2.79 (95%CI: 1.10-7.04, p=0.027) for the PECAM-1-373G allele carriers, whereas carriers of the P-Selectin-37674C allele had non-significantly elevated risk (OR=1.59, 95%CI: 0.53-4.78, p=0.406). Additionally, GpIa-C807T and GpIIIa-T1565C-PlA1/PlA2 gene polymorphisms were statistically significantly associated with spontaneous miscarriages. The frequency of GpIa-807T allele carriers was statistically significantly increased in women with miscarriages, compared with fertile controls (OR=3.36, 95%CI: 1.85-6.11, p<0.001). In comparison with subjects with genotype CC/PlA1PlA1, a dose-response relationship was identified, with OR=2.78 (95%CI: 1.49-5.17, p=0.001) for heterozygotes CT, while relative risk was markedly increased for homozygotes TT (OR=8.89, 95%CI: 2.03-38.83, p=0.001) (p<0.001 for trend). Carriers of the GpIIIa-PlA2 allele had OR=2.58 (95%CI: 1.30-5.13, p=0.006). The PECAM-1-373G allele prevalence was higher among women who miscarried, compared with controls, but did not exceed the limit for statistical significance (OR=1.19, 95%CI: 0.62-2.28, p=0.610). Although the association of the genetic heterogeneity P-Selectin-A37674C (Thr715Pro) with recurrent miscarriages was marginally statistically non-significant overall, it was statistically significant for younger women (carriers of the P-Selectin-37674C allele: OR=2.30, 95%CI: 0.91-5.81, p=0.071, <35 years: OR=3, 95%CI: 1.13-7.97, p=0.023, <30 years: OR=6.75, 95%CI: 2.02-22.58, p=0.002). Combined carriers of the GpIa-807T and GpIIIa-PlA2 alleles had remarkably elevated risk of IVF-ET failures (OR=10.13, 95%CI: 2.85-35.99, p<0.001) and miscarriages (OR=9.13, 95%CI: 2.99-27.82, p=0.001), relative to double homozygotes CC/PlA1PlA1, implying synergy between the two alleles. Similarly, an epistatic interaction between the PECAM-1-373G and P-Selectin-37674C alleles was observed, with combined carriers having OR=16.25 (95%CI: 1.44-183.10, p=0.018) for IVF-ET failures and OR=8.81 (95%CI: 1.07-72.50, p=0.024) for miscarriages, in comparison with the genotype CC/AA. The combinative analysis revealed increased risks for miscarriages and IVF-ET failures for other combinations of the four polymorphisms, as well. A very strong positive association for triple carriage of the GpIa-807T, GpIIIa-PlA2 and PECAM-1-373G alleles with IVF-ET failures, relative to the common alleles homozygotes, was determined (OR=52.50, 95%CI: 4.05-680.95, p<0.001). For the first time in the literature genetic models were calculated which predict recurrent IVF-ET failures and miscarriages risk with good diagnostic accuracy (AUC) (IVF-ET failures: 75.4% and 72.5%, miscarriages: 70.4% και 66.9%, based on the number of risk-increasing genes and alleles, respectively). From the quantitative analysis, an increasing trend of IVF-ET failures and miscarriages relative risk with the increasing number of polymorphisms and risk alleles was established. For IVF-ET failures, in comparison with low risk subjects (those with genetic burden in <2 genes), those with >2 polymorphisms had OR=13.50 (95%CI: 3.86-47.22, p<0.001) and carriers of >3 risk alleles had OR=61.56 (95%CI: 3.39-1118.78, p=0.005), as compared with low risk women (those with <2 risk alleles). Furthermore, carriers of >2 polymorphisms had OR=9.15 (95%CI: 3.03-27.63, p<0.001), whereas carriers of >3 risk alleles had OR=36.40 (95%CI: 2.13-621.87, p=0.013) for miscarriages, compared with those with <2 polymorphic genes and alleles. The above associations were more pronounced among younger women and for late miscarriages. Conclusions: This study provides epidemiological evidence supporting the role of the GpIa-807T, GpIIIa-PlA2, PECAM-1-373G and P-Selectin-37674C alleles in the pathogenesis of unexplained spontaneous abortions and IVF-ET failures, revealing the importance of platelet-associated inherited thrombophilia in women with fetal loss across the different stages of pregnancy, from implantation to the point of embryo viability. The presented genetic associations and genetic models could be used for the prediction of women with unexplained miscarriages and IVF-ET failures as well as the individualization of antiplatelet therapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vlachadis, Nikolaos
- Βλαχάδης, Νικόλαος
Subjects
dc:subject × 30- Αποβολές
- Εξωσωματική γονιμοποίηση
- Εμφύτευση
- Αποτυχίες εμφύτευσης
- Κύηση
- Αιμοπετάλια
- Γονίδια
- Θρομβοφιλία
- Πολυμορφισμοί
- Γλυκοπρωτεΐνη Ia
- Γλυκοπρωτεΐνη IIIa
- Διακυτταρικοί σύνδεσμοι
- Miscarriages
- In vitro fertilization
- IVF
- Implantation
- Implantation failures
- Pregnancy
- Platelets
- Genes
- Thrombophilia
- Polymorphisms
- GpIa
- GpIIIa
- PECAM-1
- P-selectin
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39394